Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?
EClinicalMedicine
.
2023 Feb 6:57:101845.
doi: 10.1016/j.eclinm.2023.101845.
eCollection 2023 Mar.
Authors
Francesco Passiglia
1
,
Silvia Novello
1
Affiliation
1
Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy.
PMID:
36816346
PMCID:
PMC9932644
DOI:
10.1016/j.eclinm.2023.101845
No abstract available